Skip to main content
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1976;69(Suppl 2):11–14. doi: 10.1177/00359157760690S204

The metabolism of gemfibrozil.

R A Okerholm, F J Keeley, F E Peterson, A J Glazko
PMCID: PMC1864041  PMID: 828261

Full text

PDF
11

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davison C., Benziger D., Fritz A., Edelson J. Absorption and disposition of 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, WIN 35,833, in rats, monkeys, and men. Drug Metab Dispos. 1975 Nov-Dec;3(6):520–524. [PubMed] [Google Scholar]
  2. Hucker H. B., Grady L. T., Michniewicz B. M., Stauffer S. C., White S. E., Maha G. E., McMahon F. G. Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man. J Pharmacol Exp Ther. 1971 Nov;179(2):359–371. [PubMed] [Google Scholar]
  3. THORP J. M. BIOCHEMICAL ASPECTS OF TOXICOLOGY OF ATROMID. J Atheroscler Res. 1963 Sep-Dec;3:737–739. doi: 10.1016/s0368-1319(63)80060-5. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES